These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15850943

  • 1. Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
    Vordermark D, Kölbl O.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):296-7; author reply 297. PubMed ID: 15850943
    [No Abstract] [Full Text] [Related]

  • 2. In regard to Dr. Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
    Kondziolka D, Lunsford LD, Flickinger JC.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):614-5; author reply 615-6. PubMed ID: 15890607
    [No Abstract] [Full Text] [Related]

  • 3. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.
    Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):853-60. PubMed ID: 15465203
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme.
    Linassier C, Benboubker L, Velut S, Calais G, Saudeau D, Jan M, Autret A, Berger C, Biron P, Colombat P.
    Bone Marrow Transplant; 1996 Sep 01; 18 Suppl 1():S69-72. PubMed ID: 8899180
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer: in regard to Roh et Al (Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1348-55.
    Yazici G, Cengiz M, Akyol F.
    Int J Radiat Oncol Biol Phys; 2010 Mar 15; 76(4):1278; author reply 1278. PubMed ID: 20206031
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses: in regard to Milano et al. (Int J Radiat Oncol Biol Phys 2009;73:832-837).
    Christodouleas JP, Marks LB.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1628; author reply 1628-9. PubMed ID: 19616752
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In regard to Wahl et al. (Int J Radiat Oncol Biol Phys 2008;70:477-484).
    Hannoun-Levi JM, Raoust I.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1603-4; author reply 1604. PubMed ID: 18640511
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In regard to Hoppe et al. (Int J Radiat Oncol Biol Phys 2008;72:1283-1286).
    Lo SS, Fakiris AJ, Wang JZ, Mayr NA.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):977; author reply 978. PubMed ID: 19480981
    [No Abstract] [Full Text] [Related]

  • 15. Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies?
    Lustig RA, Scott CB, Curran WJ.
    Am J Clin Oncol; 2004 Oct 01; 27(5):516-21. PubMed ID: 15596923
    [Abstract] [Full Text] [Related]

  • 16. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
    Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D.
    Cancer; 2005 Nov 15; 104(10):2168-73. PubMed ID: 16220556
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In regard to Dr. Vasanthan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153).
    van der Zee J, van Rhoon GC, Wust P.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):940-1. PubMed ID: 15936581
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.
    Colman H, Berkey BA, Maor MH, Groves MD, Schultz CJ, Vermeulen S, Nelson DF, Mehta MP, Yung WK, Radiation Therapy Oncology Group.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):818-24. PubMed ID: 16887285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.